The Ministry of Health plans to update the rules for forming a commission responsible for the list of vital drugs
Representatives of patient organizations fear that they want to be removed from control over the list of vital and essential...
Representatives of patient organizations fear that they want to be removed from control over the list of vital and essential...
Cancer drugs “Abraxane” from the American BMS and “Picray” from the Swiss Novartis, which are not included in the list...
Pharmaceutical manufacturers in the EAEU countries criticized the initiative of the Ministry of Finance to extend excise taxes on ethyl...
A number of associations of manufacturers and distributors of the pharmaceutical industry are asking the government to instruct the Ministry...
The need to save budget funds may affect the expansion of the list of drugs purchased under federal programs. Since...